Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting

Abstract

This manuscript provides nomenclature recommendations developed by an international workgroup to increase transparency and standardization of pharmacogenetic (PGx) result reporting. Presently, sequence variants identified by PGx tests are described using different nomenclature systems. In addition, PGx analysis may detect different sets of variants for each gene, which can affect interpretation of results. This practice has caused confusion and may thereby impede the adoption of clinical PGx testing. Standardization is critical to move PGx forward.

Description
item.page.description.tableofcontents
item.page.relation.haspart
Cite As
Kalman, L. V., Agúndez, J. A. G., Appell, M. L., Black, J. L., Bell, G. C., Boukouvala, S., … Zanger, U. M. (2016). Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting. Clinical Pharmacology and Therapeutics, 99(2), 172–185. http://doi.org/10.1002/cpt.280
ISSN
Publisher
Series/Report
Sponsorship
Major
Extent
Identifier
Relation
Journal
Clinical Pharmacology and Therapeutics
Source
PMC
Alternative Title
Type
Article
Number
Volume
Conference Dates
Conference Host
Conference Location
Conference Name
Conference Panel
Conference Secretariat Location
Version
Author's manuscript
Full Text Available at
This item is under embargo {{howLong}}